Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M-L Chaix

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Transplantation|June 27, 1996
Azathioprine hepatitis in kidney transplant recipients. A predisposing role of chronic viral hepatitisS Pol, R Cavalcanti, F Carnot, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 2001
The tolerance and efficacy of interferon-alpha in haemodialysis patients with HCV infection: a multicentre, prospective studyF Degos, S Pol, M L Chaix, et al.
The Journal of Antimicrobial Chemotherapy|September 18, 2014
HIV-1 subtype influences susceptibility and response to monotherapy with the protease inhibitor lopinavir/ritonavirK A Sutherland, J Ghosn, J Gregson, et al.
Journal of Virology|September 1, 1995
Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in FranceI Loussert-Ajaka, M L Chaix, B Korber, et al.
HIV Medicine|August 18, 2009
Long-term (96-week) follow-up of antiretroviral-naïve HIV-infected patients treated with first-line lopinavir/ritonavir monotherapy in the MONARK trialJade Ghosn, P Flandre, I Cohen-Codar, et al.
Gut|October 18, 2000
Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early reportH Zylberberg, Y Benhamou, J L Lagneaux, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 9, 1999
Increase of HIV-1 subtype A in Central African RepublicM C Müller-Trutwin, M L Chaix, F Letourneur, et al.
AIDS (London, England)|November 1, 1994
Sensitivity of screening kits for anti-HIV-1 subtype O antibodiesF Simon, T D Ly, A Baillou-Beaufils, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 1, 2013
Safety of hematopoietic stem cell transplantation from hepatitis B core antibodies-positive donors with low/undetectable viremia in HBV-naïve childrenP Frange, M Leruez-Ville, B Neven, et al.
HIV Medicine|June 13, 2002
Immunological and virological features of HIV-infected patients with increasing CD4 cell numbers despite virological failure during protease inhibitor-based therapyL Weiss, M Burgard, Y D Cahen, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Transplantation|June 27, 1996
Azathioprine hepatitis in kidney transplant recipients. A predisposing role of chronic viral hepatitisS Pol, R Cavalcanti, F Carnot, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 2001
The tolerance and efficacy of interferon-alpha in haemodialysis patients with HCV infection: a multicentre, prospective studyF Degos, S Pol, M L Chaix, et al.
The Journal of Antimicrobial Chemotherapy|September 18, 2014
HIV-1 subtype influences susceptibility and response to monotherapy with the protease inhibitor lopinavir/ritonavirK A Sutherland, J Ghosn, J Gregson, et al.
Journal of Virology|September 1, 1995
Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in FranceI Loussert-Ajaka, M L Chaix, B Korber, et al.
HIV Medicine|August 18, 2009
Long-term (96-week) follow-up of antiretroviral-naïve HIV-infected patients treated with first-line lopinavir/ritonavir monotherapy in the MONARK trialJade Ghosn, P Flandre, I Cohen-Codar, et al.
Gut|October 18, 2000
Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early reportH Zylberberg, Y Benhamou, J L Lagneaux, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 9, 1999
Increase of HIV-1 subtype A in Central African RepublicM C Müller-Trutwin, M L Chaix, F Letourneur, et al.
AIDS (London, England)|November 1, 1994
Sensitivity of screening kits for anti-HIV-1 subtype O antibodiesF Simon, T D Ly, A Baillou-Beaufils, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 1, 2013
Safety of hematopoietic stem cell transplantation from hepatitis B core antibodies-positive donors with low/undetectable viremia in HBV-naïve childrenP Frange, M Leruez-Ville, B Neven, et al.
HIV Medicine|June 13, 2002
Immunological and virological features of HIV-infected patients with increasing CD4 cell numbers despite virological failure during protease inhibitor-based therapyL Weiss, M Burgard, Y D Cahen, et al.
Pageof 6